dulaglutide - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
TRULICITY dulaglutide (rch) 1.5 mg/0.5 mL solution for injection prefilled pen
AUST R: 217965
Active ingredients:
dulaglutide

Dosage form:
Injection, solution

Sponsor:
Eli Lilly Australia Pty Ltd

Phone:
01800454559

From
27 Jun 2022
to
31 Dec 2024

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
A TGA web statement is available at: www.tga.gov.au/trulicity-shortage The sponsor is closely monitoring stock levels and releasing stock to wholesalers as equitably as possible. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.